Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Spyre Therapeutics CEO Sells 15,000 Shares at $86.36-$89.07 (NASDAQ: SYRE)

Spyre Therapeutics, Inc. (NASDAQ: SYRE) CEO Turtle Cameron sold 15,000 shares at prices ranging from $86.36 to $89.07 per share. Cameron’s reported ownership after the transactions stood at 552,540 shares.

Vinay Lochav | 04 September 2026

OpenAI Claims New Astra Model Overtakes Anthropic, Stirs Fresh AGI Debate

OpenAI released its latest AI model on Thursday, describing GPT-6 Astra as the world's most intelligent AI system as the ChatGPT maker aims to retake the technical lead from rival Anthropic ahead of a planned public listing. The company, valued at $852 billion, said …

Nitish Kishor | 04 September 2026

Norway's $2.3 Trillion Oil Fund Proposes Slashing US Treasury Holdings by $80 Billion

The manager of Norway's $2.3 trillion sovereign wealth fund has proposed a significant overhaul of its government bond portfolio that could reduce its holdings of US Treasuries by about $80 billion, as the fund looks to other types ofDebtto boost returns. Norges BankInvestmentManagement said …

Nitish Kishor | 04 September 2026

Teladoc Health Executive Sells 6,200 Shares at $6.30 (NYSE: TDOC)

Teladoc Health, Inc. (NYSE: TDOC) executive Nueno Carlos exercised options for 13,273 shares across two transactions on 1 September 2026. Carlos, the company’s President, International, owned 70,944 shares after those transactions.

Vinay Lochav | 04 September 2026

Volkswagen Board Approves Historic Plan to Cut Up to 50,000 Jobs

Volkswagen's supervisory board reached a surprise unanimous deal to back chief executive Oliver Blume's sweeping overhaul, which will see the German carmaker cut up to 50,000 jobs and could lead to plant closures. The company told investors on Thursday evening that the restructuring would …

Nitish Kishor | 04 September 2026

Teladoc Health (NYSE: TDOC) President Sells 7,357 Shares at $6.30 Each

Bliss Kelly, Teladoc Health, Inc. (NYSE: TDOC)’s President, U.S. Group Health, exercised options covering 15,311 shares across three transactions on September 1, 2026. The transactions were recorded at $0 per share and were followed by a sale of Teladoc shares the next day.

Vinay Lochav | 04 September 2026

EU Formally Joins US-Led Iran Sanctions Campaign as South Korea Weighs Military Role

The European Union has formally joined the US-led sanctions campaign against Iran, while South Korea said it is weighing a military role to help reopen the Strait of Hormuz, as Washington presses allies to back its war against Tehran on both financial and military …

Nitish Kishor | 04 September 2026

Travere Therapeutics CFO Sells 642 Shares at $66.37 (NASDAQ: TVTX)

Travere Therapeutics, Inc. (NASDAQ: TVTX) saw Chief Financial Officer Cline Christopher R. sell 642 shares at $66.37 per share. The transaction took place on September 2, 2026. Cline’s post-transaction ownership stood at 118,016 shares.

Vinay Lochav | 04 September 2026

Labor Day Marks Start of Fallcations as Wealthy Travelers Avoid Summer Crowds

Fall is emerging as the new peak season for luxury travel, as wealthy travelers continue shifting their holidays to September and October to avoid summer crowds, according to a new study from Virtuoso, the global luxury travel network. Fall bookings for luxury travel and …

Nitish Kishor | 04 September 2026

Global Bond Rout Deepens as Inflation Fears and Heavy Borrowing Push Yields to Multiyear Highs

A sharp sell-off in globalGovernment Bondsis exposing investor anxiety that the macroeconomic backdrop may be shifting toward persistently higher inflation, as governments struggle to rein in spending and sovereign debt. Pressure on yields reflects more than this year's rise in government borrowing and higher …

Nitish Kishor | 04 September 2026
Support

Hi! How can we help you today?

Loading…